JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Pliant Therapeutics Inc

Fechado

1.56 -1.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.56

Máximo

1.59

Indicadores-chave

By Trading Economics

Rendimento

-6.4M

-56M

Funcionários

171

EBITDA

-10M

-59M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+409.55% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-8.6M

89M

Abertura anterior

2.83

Fecho anterior

1.56

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Pliant Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de jul. de 2025, 17:53 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750 Million Windfall

25 de jul. de 2025, 15:58 UTC

Ganhos
Grandes Movimentos do Mercado

Aon Shares Rise After 2Q Earnings Beat

25 de jul. de 2025, 15:08 UTC

Grandes Movimentos do Mercado

AST SpaceMobile Shares Slide After Convertible Notes, Stock Offerings

25 de jul. de 2025, 21:40 UTC

Conversa de Mercado

Starbucks' Spending Hikes Are Misdirected -- Market Talk

25 de jul. de 2025, 21:23 UTC

Conversa de Mercado

Honeywell's Growth Seen Holding Up Despite Recent Headwinds -- Market Talk

25 de jul. de 2025, 20:40 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 20:10 UTC

Ganhos

These Stocks Moved the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 19:56 UTC

Ganhos

Correction to Why Bargain Hunters Are Flocking to 'Bin Stores' -- Barrons.com on July 20

25 de jul. de 2025, 19:14 UTC

Conversa de Mercado

Oil Futures Post Back-to-Back Weekly Losses -- Market Talk

25 de jul. de 2025, 19:10 UTC

Conversa de Mercado

U.S. Natural Gas Futures Appear to Stabilize -- Market Talk

25 de jul. de 2025, 19:01 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 18:45 UTC

Conversa de Mercado

Gold Ends Down Week on Lower Note -- Market Talk

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Sale Could Fetch Around $1B, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH in Talks to Sell Marc Jacobs -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Suitors for Marc Jacobs Include Authentic, Bluestar Alliance and WHP Global, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH Exploring Sale of Fashion Brand Marc Jacobs, Sources Say -- WSJ

25 de jul. de 2025, 17:38 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750M Windfall

25 de jul. de 2025, 17:26 UTC

Conversa de Mercado

U.S. Oil Rig Count Extends Decline -- Market Talk

25 de jul. de 2025, 17:13 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 16:46 UTC

Ganhos

Volkswagen Teases Made-in-America Audis, Porsches After $1.5 Billion Tariff Hit -- 2nd Update

25 de jul. de 2025, 16:45 UTC

Ganhos

Apple Earnings Are Next Week. Why This Analyst Says Be Cautious. -- Barrons.com

25 de jul. de 2025, 16:27 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

25 de jul. de 2025, 16:02 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Berkshire Stock Is Losing Its Buffett Premium. Now Is the Time to Buy. -- Barrons.com

25 de jul. de 2025, 15:34 UTC

Ganhos

Intel's Harsh Reality Nullifies Tariff Boost -- WSJ

25 de jul. de 2025, 15:06 UTC

Conversa de Mercado

Base Metal Prices Fall on Stronger U.S. Dollar -- Market Talk

25 de jul. de 2025, 15:05 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Comfort Systems, and More -- Barrons.com

25 de jul. de 2025, 14:45 UTC

Conversa de Mercado

Oil Rangebound Amid U.S.-EU Trade Uncertainty -- Market Talk

25 de jul. de 2025, 14:44 UTC

Conversa de Mercado

Gold Futures Set to End Week Lower on Easing Trade War Concerns -- Market Talk

25 de jul. de 2025, 14:36 UTC

Conversa de Mercado
Ganhos

Phillips 66 CEO Says California Administration Supports of LA Plant Closure -- Market Talk

Comparação entre Pares

Variação de preço

Pliant Therapeutics Inc Previsão

Preço-alvo

By TipRanks

409.55% parte superior

Previsão para 12 meses

Média 8 USD  409.55%

Máximo 17 USD

Mínimo 3 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Pliant Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

1

Comprar

5

Manter

0

Vender

Pontuação Técnica

By Trading Central

1.43 / 1.6Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Weak Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.